Asthmatics who have their illness well under control have less severe COVID-19 outcomes than those with uncontrolled asthma, according to a large study conducted by USC and Kaiser Permanente Southern California.
A new study led by an Iowa State University scientist details the structure of a critical enzyme that enables the coronavirus to resist antiviral medications. Scientists could use the study to find ways to inhibit the enzyme, possibly leading to more effective treatments.
Boston University behavioral scientist Nina Mazar analyzes different types of public health messaging that could lead to increased vaccination rates, including for COVID-19, in underserved communities in the United States.
Two University of Washington scientists have developed a statistical framework that incorporates key COVID-19 data to model the true prevalence of the disease in the United States and individual states.
In a new study from University of California San Diego School of Medicine, researchers have confirmed that patients taking statin medications had a 41 percent lower risk of in-hospital death from COVID-19.